| CAS NO: | 1229582-33-5 |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| CAS： | 1229582-33-5 |
| 分子式： | C27H27N5 |
| 分子量： | 421.54 |
| 纯度： | >98% |
| 溶解性： | DMSO |
| 存储： | Powder -20℃ 3 years; 4℃ 2 years In solvent -80℃ 6 months;-20℃ 1 month |
| 研究领域： | Neurological Disease |
| Target： | MLK3m 14 nM (IC50); LRRK2, 11 nM (IC50); FLT3, 4 nM (IC50); FLT1, 39 nM (IC50); ABL1 (T315I), 3 nM (IC50); ABL1, 6.8 nM (IC50) |
| 描述： | URMC-099 is an orally bioavailable and potent mixed lineage kinase type 3 (MLK3) (IC50=14 nM) inhibitor with with excellent blood-brain barrier penetration properties. |
m.cnreagent.com